Methamphetamine (METH) is an addictive psychostimulant that is associated with significant physical and psychological harm. Magnetic resonance imaging (MRI) is a non-invasive and powerful imaging modality that can reveal structural and functional brain changes. We conducted a systematic review to identify and appraise the existing literature examining brain MRI changes associated with METH exposure. A comprehensive literature search was conducted on PubMed, Web of Science, and Scopus. Any study that used MRI to evaluate brain changes in people who used or had been exposed to METH using MRI were included. Data were collected on study design, participant demographics, METH use parameters, MRI acquisition details, and key findings. Quality appraisal was conducted using an a priori quality appraisal tool. One hundred and thirty seven studies with 8313 participants were included in our review. Nearly all were conducted in adults/adolescents (121/137, 88%), and most studies were cross-sectional (107/137, 78%). Task-based functional MRI was the most common modality used (48/137, 35%), followed by structural MRI (38/137, 28%). Quality appraisal scores ranged from 40 – 100% (mean 88%). Overall, METH is associated with numerous adverse changes in brain structure and function, including reduced grey matter volume and thickness in frontal and limbic regions and decreased fractional anisotropy in various white matter structures, with associated socio-emotional dysregulation, impaired decision-making and learning processes, and cognitive deficits. Targeted, higher-order, or multi-modal MRI sequences may be useful in further clarifying the impact of METH on the brain and evaluating the use of potential therapeutic agents.

The authors have declared no competing interest.

We acknowledge funding support received from the Fred Lewis foundation and the Hugh and Moira Green Foundation.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors